We observed significantly higher CAROTI cell numbers in the spleens and tumours of mice administered OVA‐Clec9A‐TNE and CAROT cell adoptive transfer (Figure 6a and b) compared to the other treatment groups. Here, CLEC9A is linked to neoplasm.